1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CXCL1 mediates leptomeningeal metastasis growth
    Meeting Abstract

    Osman, A.; Remsik, J.; Wijetunga, A.; Snyder, J.; Manoranjan, B.; Nobre, A.; Freret, M.; Guber, D.; Chabot, K.; Piedrafita-Ortiz, S.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Global expansion of GBM AGILE: A phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Weller, M.; Berry, D.; Blondin, N.; Boulmay, B.; Buxton, M.; Chinot, O.; Colman, H.; de la Fuente, M.; de Groot, J.; Drappatz, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Improving adherence to cancer care in underserved patients with central nervous system tumors
    Meeting Abstract

    Elshiekh, C.; Phillips, A.; Rodriguez, A.; Narang, B.; Gany, F.; Budhu, J.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • CXCR4-targeted pet imaging of central nervous system lymphoma and glioma using [(68)GA]GA-Pentixafor
    Meeting Abstract

    Werner, J. M.; Tomasich, E.; Berghoff, A. S.; Wöhrer, A.; Albert, N. L.; Mayerhoefer, M. E.; Galldiks, N.; Traub-Weidinger, T.; Hacker, M.; Preusser, M.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Perry, J. R.; Cloughesy, T.; Berry, D. A.; Buxton, M. B.; Colman, H.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Mellinghoff, I. K.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P.; Ramsingh, G.; Prabhakar, P.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • CRISPR-Cas9 genetic targeting of metastatic pancreatic cancer
    Meeting Abstract

    Bowland, K.; Lai, J.; Teh, S. S. K.; Bennett, A.; Skaist, A.; Zhang, Y.; Thompson, E.; Wheelan, S. J.; Hruban, R. H.; Karchin, R.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • CAR T-cell-derived TNF drives cytokine release syndrome and enhances M1 macrophage differentiation
    Meeting Abstract

    Lindenbergh, P. L.; Giavridis, T.; Vivier, O.; Lopez, M.; Dobrin, A.; Sadelain, M.
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • Loss of heterozygosity is low for specific HLA alleles in cancer patients with driver mutations
    Meeting Abstract

    Roy, C.; Sewastianik, T.; Halvey, P.; Montesion, M.; Jindal, A.; Vallaster, M.; Lam, H.; Garrity, S.; Shapiro, G.; Klebanoff, C. A.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save
  • THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers
    Meeting Abstract

    Narayan, S.; Swanson, N.; Drain, A.; Gareau, K.; Rouillard, N.; Liang, J.; Liu, H. W.; Brown, L.; Lamothe, R.; Greenberg, P. D.; more...
    Molecular Therapy (2024)

    Fulltext@MSK | Save